Madrigal Pharmaceuticals (MDGL) Inventory Average (2024 - 2026)

Madrigal Pharmaceuticals (MDGL) has 3 years of Inventory Average data on file, last reported at $93.5 million in Q1 2026.

• Inventory Average for Q1 2026 came in at $93.5 million, up 109.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $93.5 million (up 109.29% YoY), and the FY2025 annual result was $54.5 million, changed N/A from the prior year.
• Inventory Average rose to $93.5 million in Q1 2026 per MDGL's latest filing, from $72.1 million in the prior quarter.
• Over five years, Inventory Average peaked at $93.5 million in Q1 2026 and troughed at $4.0 million in Q2 2024.
• A 3-year average of $46.2 million and a median of $52.0 million in 2025 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2025 and 2026: Inventory Average surged 1398.08% in 2025, then soared 109.29% in 2026.
• A 3-year view of Inventory Average shows it stood at $21.4 million in 2024, then surged by 236.95% to $72.1 million in 2025, then grew by 29.66% to $93.5 million in 2026.
• Business Quant data shows MDGL's Inventory Average at $93.5 million in Q1 2026, $72.1 million in Q4 2025, and $66.4 million in Q3 2025.